Brentuximab

Tax included
Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies.
MedChemExpress 
HY-P99151

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
Cancer-programmed cell death
CAS
2088770-90-3